Articles > Popular publications > PR Newswire press releases > April-June 2007 > Friday, May 11

Article: Eisai Obtains Favorable Ruling in Aciphex(R) Patent Infringement Lawsuit Against Teva Pharmaceuticals and Dr. Reddy's Laboratories.

Article from:
PR Newswire
Article date:
May 11, 2007
Copyright

TOKYO, Japan, and WOODCLIFF LAKE, N.J., May 11 /PRNewswire/ -- Eisai Co., Ltd. and its U.S. subsidiary Eisai Inc. (collectively "Eisai") today announced that the United States District Court for the Southern District of New York has ruled in Eisai's favor with respect to Eisai's patent infringement lawsuit against Teva Pharmaceuticals and Dr. Reddy's Laboratories concerning Aciphex(R) (generic name: rabeprazole sodium, Product Name in Japan: Pariet(R)).

As previously announced, Eisai filed the infringement actions in November 2003 contesting Teva Pharmaceuticals and Dr. Reddy's Laboratories' submissions of abbreviated new drug applications (ANDAs) to the FDA for ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Eisai Donates More Than 80 Murals to Hospitals Around the ...
PR Newswire;  November 11, 2009 ;     700+ words ... ... 11 /PRNewswire/ -- Eisai Inc. today announced ... hospitals across the United States. The multi-panel ... more than 1,200 of Eisai's field employees ... first product in the United States in 1997 and has rapidly ... approximately $3.7 billion. Eisai Inc.'s areas of commercial ...

Article: Eisai Inc. to Promote Pfizer's Anti-Seizure Medicine, ...
Business Wire;  July 25, 2002 ;     700+ words ... ... BUSINESS WIRE)--July 25, 2002 Eisai Inc. and Pfizer Inc. today ... collaborative agreement in which Eisai has acquired exclusive U ... the terms of the agreement, Eisai Inc. will develop educational ... Cerebyx has been available in the United States since 1996 and was acquired ...

Article: Eisai Expands Neurology Presence With Launch of Cerebyx(R) ...
PR Newswire;  September 17, 2002 ;     700+ words ... ... 1996. In July 2002, Eisai announced that it had ... Cerebyx(R) in the United States. Status epilepticus ... subsidiary of Tokyo-based Eisai Co., Ltd., a research ... Established in 1995, Eisai Inc. began marketing its first product in the United States in 1997 and has rapidly ...

Article: Eisai obtains United States ...
BIOTECH Patent News;  November 1, 2003 ;     538 words ...Eisai Co., Ltd (Tokyo, Japan) has patented a method for producing a cell to which angiogenesis-inducing ability has been imparted ...

Article: United States: Eisai wins approval for GERD ...
TendersInfo;  July 3, 2008 ;     612 words ...Byline: pinto03 Eisai Corporation of North America, a wholly-owned subsidiary of Tokyo-based Eisai, has announced that the FDA has approved Aciphex 20mg for the short-term treatment of gastroesophageal reflux disease in adolescents ages ...

Article: FTC clears Eisai takeover of MGI ...
Chain Drug Review;  February 4, 2008 ;     583 words ...The Federal Trade Commission has cleared Eisai Co.'s takeover of MGI Pharma Inc. The acquisition is valued at $3.9 billion.

Article: Eisai obtains United States patent.(protein, ...
BIOTECH Patent News;  June 1, 2001 ;     578 words ...Eisai Co Ltd (Japan) has patented a protein, p100, which has a molecular weight of about 100 kDa, being associated in vivo with ...

Article: Eisai rises in the west
Pharmaceutical Executive;  February 1, 2003 ;     700+ words ... ... anchor in the United States. In turn, its US subsidiary Eisai Inc. is playing ... building up Eisai's reputation ... operations in the United States, all-as ... Matsuno. "Eisai wanted to build ... company in the United States, but doing ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives